Recent examples include the work of Wang and colleagues, who identified a series of peptides that interact specifically with the DNA binding domain of ERG, leading to proteolytic degradation of the ERG protein, and attenuation of ERG-mediated transcription, chromatin recruitment, protein-protein interactions, cell invasion and proliferation, and tumor growth (Wang et al., 2017). The gene discussed is ERG; the disease is neoplasm.